210 results
Page 4 of 11
8-K
EX-99.1
fdh8ke6q
27 Jun 19
Biocryst Begins Enrollment of Phase 1 Trial of BCX9930, an Oral Factor D Inhibitor for Complement-Mediated Diseases
4:29pm
8-K
EX-10.1
xwowep7i 1lch
4 Jun 19
Departure of Directors or Certain Officers
3:00pm
S-8
EX-99.1
c9qdirv4m 38f
29 Apr 19
Registration of securities for employees
4:46pm
8-K
EX-99.2
rj85cnxjfwht sz
4 Mar 19
BioCryst Reports Fourth Quarter and Full Year 2018 Financial Results
7:28am
8-K
EX-10.1
xtdo vid8w4i
31 Oct 18
Departure of Directors or Certain Officers
9:37am
424B2
vtf3otuirbbae3s
3 Aug 18
Prospectus for primary offering
4:10pm
424B5
12241
1 Aug 18
Prospectus supplement for primary offering
4:02pm